Implications of the Human Microbiota for Health and Disease
Recruiting
- Conditions
- Human Microbiota
- Registration Number
- NCT04203303
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to advance the understanding of human health and disease as it relates to environmental factors that may affect intestinal and non-intestinal microbiota.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
- Age 18 years of age or older
- Able to provide informed consent
Exclusion Criteria
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Microbiome Differences 10 years compare the relative abundance of specific microorganism groups
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link gut microbiota to autoimmune disease progression in NCT04203303?
How does the human microbiota influence efficacy of immunotherapy in cancer patients?
What biomarkers correlate with microbiota composition changes in metabolic disorders?
Are there specific probiotic interventions that modulate pathogenic microbiota in IBD?
What adverse events are associated with microbiota-targeted therapies in clinical trials?
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Rochester, Minnesota, United States
Mayo Clinic🇺🇸Rochester, Minnesota, United StatesShahid KarimContact507-422-0763Karim.Shahid@mayo.eduNick WozniakContact(507) 255-8794Wozniak.Nicholas@mayo.eduVirend Somers, MDPrincipal Investigator